Epstein Secrets

ted by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behi

one. Fox Business <https://playvideo.bulletinintelligence.com/85e5793536ba4b538292e67376da457e? pubid=fbi&transcript=y> (11/23, 139K) featured Rep. Tom Reed (R-NY) and Rep. Josh Gottheimer (D-NJ), co- chairs of the Problem Solvers caucus. Asked about a new COVID-19 aid package, Gottheimer said that we "fe

ed by more than $10 billion in U.S taxpayer dollars. The government is also supporting an experimental vaccine from Sanofi/GSK and one from startup Novavax, which are expected to begin large trials in the U.S. in the coming weeks. Merck, which has received far less funding, is a few months further behin

united, but still fear for their lives." Reps. Reed And Gottheimer Say COVID-19 Aid Package Can Be Done. Fox BusinessVI (11/23, 139K) featured Rep. Tom Reed (R-NY) and Rep. Josh Gottheimer (D- NJ), co-chairs of the Problem Solvers caucus. Asked about a new COVID-19 aid package, Gottheimer said that we "f

at's got to rest with physicians and patients." Novavax Reports Positive Results For Vaccine Candidate. The New York Times (8/4, 18.61M) reports, "Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announce

, however, that "opponents say the spending is not enough to erase an estimated $20 billion maintenance backlog." WENY-TVVi (8/4, 2K) reports Rep. Tom Reed (R-NY) said, "It was resoundingly supported. That's why we were able to get that 75% consensus and the Problem Solvers Caucus behind it." Trump Say